Study shows that impaired fasting glucose is less accurate diagnostic tool…   Patients with normal glucose tolerance (NGT) and 1-hour post-load plasma glucose level of ≥155 mg/dl have a higher cardio-metabolic risk profile compared to patients with NGT and impaired glucose tolerance (IGT), according to The Journal of Clinical Endocrinology …

Insulin has different impact on fasting plasma glucose and day-to-day changes… The duration of action for degludec is approximately 42 hours and is much longer than the duration of action of glargine. Due to degludec pharmacokinetics, it leads to a slower absorption rate from the injection site to the blood …

A study supports previous findings that better-educated people have greater access to resources that promote healthy living, such as gym memberships or homes in neighborhoods that encourage walking. Researchers examined data from the U.S. National Health and Nutrition Examination Survey 2007-2012, and found adults with a college degree who were …

Lackluster results for liraglutide as adjunct to insulin therapy: Novo Nordisk announced that it will not pursue an expanded indication for liraglutide (Victoza) as an add-on treatment to insulin for type 1 diabetes because of disappointing phase III trial results. The company released top-line results for the ADJUNCT ONE randomized …

They decided to initiate a phase 3a program with oral semaglutide; a once-daily oral formulation of the long-acting GLP-1 analogue semaglutide. The decision follows the encouraging results of the proof-of-concept phase 2 trial and the subsequent consultations with regulatory authorities. Novo Nordisk intends to initiate a global phase 3a program, …

What every patient needs to have to save their lives. For more information about preparing your diabetes supplies for an emergency, watch this “How to Pack Your Kit” video. A list of what you need from Eli Lilly — English version / Spanish version.  

Empagliflozin/metformin is new combo medication for type 2 diabetes. More information coming in next week’s newsletter.

Two weeks ago, a patient came in to the pharmacy complaining that his feet were burning and sore, and he was developing blisters on the top of his left foot. The patient had diabetes for about 13 years and had recently been running an A1c of 7.9. He was also …

We have been at the U.S. Pro Challenge in Colorado this past week and after seven grueling days and 865 miles, Javier Megias of Team NovoNordisk was crowned Most Aggressive Rider. This rider, who lives with type 1 diabetes, is also the only rider who has managed to finish every …

New insulin now available: Humalog® 200 units/mL KwikPen®. See Product of the Week.